Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 142 clinical trials
Measurement of Renal Functional Reserve Change In Patients With SRC Before and After Laparoscopic Deroofing

Renal functional reserve may be improved in patients with simple renal cysts after laparoscopic deroofing.

  • 0 views
  • 24 Jan, 2021
  • 1 location
Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients

Research design: randomized, double-blind, placebo-controlled crossover study to evaluate the putative interference of low-dose aspirin (for 8 weeks) on enalapril antiproteinuric properties in microalbuminuric type 2 diabetes mellitus patients

diabetes mellitus
type 2 diabetes mellitus
  • 0 views
  • 07 Nov, 2020
  • 1 location
Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy

The study was a 48-week multicenter, randomized, double-blind, placebo-controlled trial that included 8 weeks of pre-screening and lifestyle education, 32 weeks of treatment, and 16 weeks of follow-up.To observe the efficacy and safety of umbilical cord mesenchymal stem cell infusion in Chinese patients with type 2 diabetic nephropathy who received …

  • 0 views
  • 27 Jan, 2021
  • 1 location
Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease

This is a Phase 3, open-label, repeat-dose study designed to assess liver safety, non-liver safety, and efficacy in subjects who previously experienced liver chemistry test abnormalities while treated with tolvaptan and were permanently discontinued from the drug for that reason. Up to 50 eligible subjects will be enrolled and treated …

renal disease
body mass index
tolvaptan
chronic kidney disease
hypertension
  • 0 views
  • 04 Feb, 2021
  • 9 locations
Comprehensive Management of Diabetic Patients With Renal Impairment : Impact on Blood Pressure and Glycemic Control

Diabetes is the leading cause of end-stage renal disease in developed countries. Hypertension and metabolic control are known to affect the progression of renal deficiency and patient's outcome. Our project aims at implementing a multidisciplinary and systematic approach of diabetic patients with renal deficiency, and at evaluating the impact of …

diabetes
renal failure
nephropathy
hypertension
  • 10 views
  • 07 Nov, 2020
  • 1 location
Evaluation of Renal Sodium Excretion After Salt Loading in Heart Failure With Preserved Ejection Fraction

Heart failure (HF) affects 2-3% of the population, and is characterized by impaired sodium balance which results in fluid overload. Ejection fraction, a measure of systolic function, is reduced in only about half of all HF patients. Incidence of heart failure with preserved ejection fraction (HFpEF) has increased in the …

medical therapy
diuretics
furosemide 40 mg
0.9% sodium chloride
  • 1 views
  • 25 Jan, 2021
  • 1 location
CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients

This is a Phase II/III, Single-center, Prospective, Open-label, Single Arm Study of 30 Simultaneous Kidney Pancreas recipients who received a transplant at least 3 months, but no more than 5 years prior, with a history of tremors following transplantation.

  • 1 views
  • 24 Jan, 2021
  • 1 location
Efficacy Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease

ventricular ejection fraction (LVEF [below 55%]) and chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR [between 20 and 60 mL/min, with at least 30% of participants with eGFR <30

  • 0 views
  • 14 Feb, 2021
  • 74 locations
Potassium Supplementation in CKD

CKD, but this has not been performed. The aim of this study is to study the renoprotective effect of potassium supplementation in patients with CKD (stage 3b or 4, i.e. estimated glomerular filtration

glomerular filtration rate
hypertension
potassium
nephropathy
hypertensive medication
  • 60 views
  • 23 Jan, 2021
  • 4 locations
Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia

abnormality (transaminases greater than 5 reference values), glomerular filtration rate lesser than 30 ml/min/1.73m^2, history of lung fibrosis, advanced or metastatic cancer. Sample size: 1,200 participants

pneumonia
organ failure
covid-19
acute respiratory distress
cancer
  • 62 views
  • 18 Feb, 2021
  • 7 locations